Clinical Research and Epidemiology in Diabetes and Endocrinology

糖尿病和内分泌学的临床研究和流行病学

• 批准号: 10437787
• 负责人: TODD T BROWN
• 金额: $ 33.08万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-30 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10437787
• 关键词: Clinical Research; Diabetes Mellitus; Endocrinology; clinical epidemiology

PROJECT SUMMARY The Clinical Research and Epidemiology in Diabetes and Endocrinology Training Program at Johns Hopkins University is applying for its third competitive renewal after completing 15 years of funding. Our training program at Johns Hopkins, established in 2002, is devoted to clinical and epidemiologic research in diabetes and endocrinology. Fifteen years later, it remains the only one of its kind in the US. Thus far, we have successfully trained 36 young scholars (17 pre-docs and 19 post docs) who have produced 128 peer-reviewed scientific papers and who hold research positions across the country. During the last funding cycle, we trained 4 under-represented minorities and 13 women. Our program includes 3 pre-doctoral and 2 post-doctoral slots. Following the untimely deaths of Drs. Saudek and Brancati, former program leaders, Dr. Sherita Golden, an endocrinologist cross-trained in epidemiology, assumed leadership of the training program. The new leadership team, supported by an Executive and Advisory Committee, proposes a fourth cycle of funding with the following specific aims: (1) to recruit a diverse group of young trainees in endocrinology (post-docs) and epidemiology (pre-docs) from a national pool of talent attracted to Johns Hopkins; (2) to enroll them in rigorous, thesis-bearing Masters' and PhD programs in Epidemiology and Clinical Investigation in the Johns Hopkins Bloomberg School of Public Health; (3) to expose them to a strong team-oriented, multi-disciplinary clinical and epidemiologic research culture in the Welch Center for Prevention, Epidemiology, and Clinical Research—the premier educational home for clinical research training at Johns Hopkins; (4) to guide each trainee to an experienced, NIH-funded mentor who will take responsibility for the successful completion of a significant thesis project; (5) to expand research training opportunities in implementation science through the Armstrong Institute for Patient Safety and Quality. To accomplish these goals, our program brings together faculty and trainees from the Divisions of Adult and Pediatric Endocrinology and General Internal Medicine (School of Medicine), the Department of Epidemiology (School of Public Health), the Welch Center for Prevention, Epidemiology, and Clinical Research, and the School of Nursing. Twenty mentors will serve as primary faculty and were selected for their expertise, excellence in mentoring, and active NIH funding. New mentors have been added with expertise in population health, implementation science, gastroenterology, pediatric obesity, and renal and cancer epidemiology. If our proposal is successful, then Johns Hopkins will continue to play a major national role in training the next generation of patient- and population-oriented researchers in diabetes and endocrinology.

项目总结 糖尿病和内分泌学培训项目的临床研究和流行病学 约翰霍普金斯大学正在申请第三次竞争性续签，在完成了15年的 资金问题。我们在约翰霍普金斯大学的培训项目成立于2002年，致力于临床和 糖尿病和内分泌学的流行病学研究。15年后，它仍然是唯一一个 在美国是同类产品中的一种。到目前为止，我们已经成功地培训了36名青年学者(17名博士前和 19名博士后)发表了128篇同行评议的科学论文，并进行了研究 全国各地的职位。在上一个筹资周期中，我们培训了4名任职人数不足的人员 少数民族和13名女性。我们的项目包括3个博士后和2个博士后。 在Saudek博士和Brancati博士英年早逝之后，前项目负责人Sherita博士 戈登是一位接受过流行病学交叉培训的内分泌学家，他担任了这次培训的负责人 程序。新的领导团队在执行和咨询委员会的支持下， 提出第四个筹资周期，具体目标如下：(1)招募多元化群体 来自国家人才库的年轻内分泌学(博士后)和流行病学(博士后)学员 被约翰·霍普金斯大学吸引的人才；(2)让他们进入严格的、有论文背景的硕士和 约翰霍普金斯大学彭博学院流行病学和临床研究博士项目 公共卫生；(3)让他们接触到强大的以团队为导向的、多学科的临床和 韦尔奇预防、流行病学和临床中心的流行病学研究文化 研究-约翰霍普金斯大学临床研究培训的首要教育之家；(4) 指导每个学员去找一位经验丰富的、由NIH资助的导师，他将负责 成功完成一项重大论文项目；(5)扩大研究培训机会 通过阿姆斯特朗患者安全和质量研究所的实施科学。至 为了实现这些目标，我们的计划汇集了以下部门的教职员工和实习生 成人和儿童内分泌学和普通内科(医学院) 流行病学系(公共卫生学院)，韦尔奇预防中心， 流行病学、临床研究和护理学院。20名导师将担任 并因他们的专业知识、卓越的指导能力和活跃的NIH而被选中 资金问题。增加了新的导师，具有人口健康、实施 科学、胃肠病学、儿童肥胖症以及肾脏和癌症流行病学。如果我们的提议 如果成功，那么约翰·霍普金斯大学将继续在全国范围内发挥重要的作用 一代以患者和人群为导向的糖尿病和内分泌学研究人员。